Procalcitonin (PCT) and C-reactive Protein (CRP) as severe systemic infection markers in febrile neutropenic adults
Open Access
- 22 November 2007
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 7 (1), 137
- https://doi.org/10.1186/1471-2334-7-137
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre studyClinical Microbiology & Infection, 2004
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- Assessment of Procalcitonin as a Diagnostic Marker of Underlying Infection in Patients with Febrile NeutropeniaClinical Infectious Diseases, 2001
- Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor IIBritish Journal of Haematology, 2000
- Assessment of Measuring Circulating Levels of Interleukin‐6, Interleukin‐8, C‐Reactive Protein, Soluble Fcy Receptor Type III, and Mannose‐Binding Protein in Febrile Children with Cancer and NeutropeniaClinical Infectious Diseases, 1999
- Diagnostic Value of Procalcitonin Serum Levels in Neutropenic Patients with Fever: Comparison with Interleukin-8Scandinavian Journal of Infectious Diseases, 1999
- Serum Calcitonin Precursors in Sepsis and Systemic InflammationJournal of Clinical Endocrinology & Metabolism, 1998
- C-reactive proteinCurrent Opinion in Infectious Diseases, 1997
- Procalcitonin in patients with and without immunosuppression and sepsisInfection, 1996
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992